Select Page

A top U.S. health official said on Friday that the government expects to have access to over 1 million doses of Regeneron Pharmaceutical Inc’s and Eli Lilly’s & Co’s antibody treatments for COVID-19 in 2020.

The official, speaking on a call with reporters, said that the government will allocate the treatments to the states based on need, similar to the mechanism they used with Gilead Sciences Inc’s antiviral drug remdesivir for COVID-19.

Both companies have said the drugs were shown to work in clinical trials and that they have submitted an emergency use authorization to the U.S. Food and Drug Administration.

(Excerpt) Read more at:

https://finance.yahoo.com/news/hhs-expects-over-1-mln-155417949.html?guccounter=1&guce_referrer=aHR0cDovL3d3dy5mcmVlcmVwdWJsaWMuY29tLw&guce_referrer_sig=AQAAAIZNrXaCx1m0EBLkFS9Yxhb3Uj5tbNU0C6_kZK1llATLJz-2YSR9mpb9IRIJnP-88s3WpQK0jf2vMy0sQwTO3TxPV4V9NWSxsL_yqzTtbPgGRBAQjz3thqaxD-YKxmimWfcmm7C3Vy4Xev5i9xfIjMGY8j4yAs4T8sJ0W6zKbpVK

Copyright © 2013 - 2020 West Wave Publishing, LTD